Progress in Elucidating Potential Markers and Mechanisms of Rapid Protection Conferred by the VSV-Vectored Ebola Virus Vaccine

ABSTRACT Research progress over the past 20 years has yielded several experimental Ebola virus (EBOV) vaccine candidates, which were shown to be effective in nonhuman primates when given 28 days before a lethal challenge. Of these, the vesicular stomatitis virus (VSV)-vectored vaccine against EBOV (...

Description complète

Enregistré dans:
Détails bibliographiques
Auteur principal: Gary Wong
Format: article
Langue:EN
Publié: American Society for Microbiology 2019
Sujets:
Accès en ligne:https://doaj.org/article/cc4d4dfa7ac14fefb4b974a9957f2471
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!